1235 related articles for article (PubMed ID: 18552700)
21. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
22. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for fluconazole-resistant candidemia.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Aznar-Martín J; Cisneros JM; Ortiz-Leyba C
Antimicrob Agents Chemother; 2010 Aug; 54(8):3149-54. PubMed ID: 20498325
[TBL] [Abstract][Full Text] [Related]
24. [Study on the morbidity and pathogens of patients with candidemia at the intensive care unit].
Yin QQ; Zhang YT; Fang Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):464-8. PubMed ID: 18956679
[TBL] [Abstract][Full Text] [Related]
25. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
26. Candidemia in neonatal intensive care unit.
Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Marchetti O; Bille J; Fluckiger U; Eggimann P; Ruef C; Garbino J; Calandra T; Glauser MP; Täuber MG; Pittet D;
Clin Infect Dis; 2004 Feb; 38(3):311-20. PubMed ID: 14727199
[TBL] [Abstract][Full Text] [Related]
28. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
30. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
31. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
32. Distribution of Candida species among bloodstream isolates.
Al-Jasser AM; Elkhizzi NA
Saudi Med J; 2004 May; 25(5):566-9. PubMed ID: 15138521
[TBL] [Abstract][Full Text] [Related]
33. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.
Rodríguez D; Almirante B; Cuenca-Estrella M; Rodríguez-Tudela JL; Mensa J; Ayats J; Sanchez F; Pahissa A;
Clin Microbiol Infect; 2010 Nov; 16(11):1676-82. PubMed ID: 20219079
[TBL] [Abstract][Full Text] [Related]
34. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
35. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.
Trick WE; Fridkin SK; Edwards JR; Hajjeh RA; Gaynes RP;
Clin Infect Dis; 2002 Sep; 35(5):627-30. PubMed ID: 12173140
[TBL] [Abstract][Full Text] [Related]
36. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient.
Mahieu LM; Van Gasse N; Wildemeersch D; Jansens H; Ieven M
Pediatr Crit Care Med; 2010 Mar; 11(2):240-5. PubMed ID: 19794324
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals.
Bassetti M; Trecarichi EM; Righi E; Sanguinetti M; Bisio F; Posteraro B; Soro O; Cauda R; Viscoli C; Tumbarello M
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):325-31. PubMed ID: 17350205
[TBL] [Abstract][Full Text] [Related]
38. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
40. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.
Foongladda S; Sakulmaiwatana P; Petlum P; Vanprapar N
J Med Assoc Thai; 2004 Jan; 87(1):92-9. PubMed ID: 14971541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
